Literature DB >> 27793691

Glucose level decline precedes dementia in elderly African Americans with diabetes.

Hugh C Hendrie1, Mengjie Zheng2, Wei Li3, Kathleen Lane2, Roberta Ambuehl4, Christianna Purnell5, Frederick W Unverzagt6, Alexia Torke7, Ashok Balasubramanyam8, Chris M Callahan7, Sujuan Gao2.   

Abstract

INTRODUCTION: High blood glucose levels may be responsible for the increased risk for dementia in diabetic patients.
METHODS: A secondary data analysis merging electronic medical records (EMRs) with data collected from the Indianapolis-Ibadan Dementia project (IIDP). Of the enrolled 4105 African Americans, 3778 were identified in the EMR. Study endpoints were dementia, mild cognitive impairment (MCI), or normal cognition. Repeated serum glucose measurements were used as the outcome variables.
RESULTS: Diabetic participants who developed incident dementia had a significant decrease in serum glucose levels in the years preceding the diagnosis compared to the participants with normal cognition (P = .0002). They also had significantly higher glucose levels up to 9 years before the dementia diagnosis (P = .0367). DISCUSSION: High glucose levels followed by a decline occurring years before diagnosis in African American participants with diabetes may represent a powerful presymptomatic metabolic indicator of dementia.
Copyright © 2016 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  African Americans; Alzheimer disease; Dementia; Diabetes; Early detection; Electronic medical records; Glucose levels; Longitudinal risk factors

Mesh:

Substances:

Year:  2016        PMID: 27793691      PMCID: PMC5318260          DOI: 10.1016/j.jalz.2016.08.017

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  28 in total

1.  Type 2 diabetes and late-onset Alzheimer's disease.

Authors:  D Cheng; J Noble; M X Tang; N Schupf; R Mayeux; J A Luchsinger
Journal:  Dement Geriatr Cogn Disord       Date:  2011-07-15       Impact factor: 2.959

2.  Prevalence rates for dementia and Alzheimer's disease in African Americans: 1992 versus 2001.

Authors:  Kathleen S Hall; Sujuan Gao; Olusegun Baiyewu; Kathleen A Lane; Oye Gureje; Jianzhao Shen; Adesola Ogunniyi; Jill R Murrell; Frederick W Unverzagt; Jeanne Dickens; Valerie Smith-Gamble; Hugh C Hendrie
Journal:  Alzheimers Dement       Date:  2009-05       Impact factor: 21.566

3.  Change in blood pressure and incident dementia: a 32-year prospective study.

Authors:  Robert Stewart; Qian-Li Xue; Kamal Masaki; Helen Petrovitch; G Webster Ross; Lon R White; Lenore J Launer
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

Review 4.  The worldwide diabetes epidemic.

Authors:  David W Lam; Derek LeRoith
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

5.  Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.

Authors:  Courtney L Sutphen; Mateusz S Jasielec; Aarti R Shah; Elizabeth M Macy; Chengjie Xiong; Andrei G Vlassenko; Tammie L S Benzinger; Erik E J Stoops; Hugo M J Vanderstichele; Britta Brix; Heather D Darby; Manu L J Vandijck; Jack H Ladenson; John C Morris; David M Holtzman; Anne M Fagan
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

6.  Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans.

Authors:  H C Hendrie; B O Osuntokun; K S Hall; A O Ogunniyi; S L Hui; F W Unverzagt; O Gureje; C A Rodenberg; O Baiyewu; B S Musick
Journal:  Am J Psychiatry       Date:  1995-10       Impact factor: 18.112

7.  The 32-year relationship between cholesterol and dementia from midlife to late life.

Authors:  M M Mielke; P P Zandi; H Shao; M Waern; S Östling; X Guo; C Björkelund; L Lissner; I Skoog; D R Gustafson
Journal:  Neurology       Date:  2010-11-10       Impact factor: 9.910

8.  Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization.

Authors:  Bessie Ann Young; Elizabeth Lin; Michael Von Korff; Greg Simon; Paul Ciechanowski; Evette J Ludman; Siobhan Everson-Stewart; Leslie Kinder; Malia Oliver; Edward J Boyko; Wayne J Katon
Journal:  Am J Manag Care       Date:  2008-01       Impact factor: 2.229

9.  The association of duration of type 2 diabetes with cognitive performance is modulated by long-term glycemic control.

Authors:  Rebecca K West; Ramit Ravona-Springer; James Schmeidler; Derek Leroith; Keren Koifman; Elizabeth Guerrero-Berroa; Rachel Preiss; Hadas Hoffman; Jeremy M Silverman; Anthony Heymann; Michal Schnaider-Beeri
Journal:  Am J Geriatr Psychiatry       Date:  2014-01-23       Impact factor: 4.105

10.  Association of type 2 diabetes with brain atrophy and cognitive impairment.

Authors:  Rosebud O Roberts; David S Knopman; Scott A Przybelski; Michelle M Mielke; Kejal Kantarci; Gregory M Preboske; Matthew L Senjem; Vernon S Pankratz; Yonas E Geda; Bradley F Boeve; Robert J Ivnik; Walter A Rocca; Ronald C Petersen; Clifford R Jack
Journal:  Neurology       Date:  2014-03-19       Impact factor: 9.910

View more
  4 in total

1.  Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health.

Authors:  Mary Ganguli; Emiliano Albanese; Sudha Seshadri; David A Bennett; Constantine Lyketsos; Walter A Kukull; Ingmar Skoog; Hugh C Hendrie
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jan-Mar       Impact factor: 2.703

2.  Changes of glucose levels precede dementia in African-Americans with diabetes but not in Caucasians.

Authors:  Hugh C Hendrie; Mengjie Zheng; Kathleen A Lane; Roberta Ambuehl; Christianna Purnell; Shanshan Li; Frederick W Unverzagt; Michael D Murray; Ashok Balasubramanyam; Chris M Callahan; Sujuan Gao
Journal:  Alzheimers Dement       Date:  2018-04-18       Impact factor: 21.566

Review 3.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

4.  Letter.

Authors:  Ara S Khachaturian
Journal:  Alzheimers Dement (Amst)       Date:  2017-11-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.